[144] Ares Management Corporation SEC Filing

Rhea-AI Filing Summary

Form 144 notice for ARES common stock: proposed sale of 300,000 shares through Morgan Stanley Smith Barney on 09/03/2025 with an aggregate market value of $53,934,000. The filing shows 215,934,693 shares outstanding, and states the 300,000 shares were acquired as Founders Shares on 05/01/2014 from the issuer. The record of related activity lists nine 10b5-1 sales by TJ CAPITAL INVESTORS LLC between 08/20/2025 and 09/02/2025 totaling 1,134,483 shares for gross proceeds of $203,457,192.45. The filer certifies no undisclosed material adverse information and references reliance on Rule 10b5-1 trading plans where applicable.

Positive

• Transparent disclosure of proposed sale with broker, date, share count, and market value
• History of 10b5-1 trades is provided, including gross proceeds and dates, aiding market transparency
• Origins of shares disclosed (Founders Shares acquired from issuer on 05/01/2014)

Negative

• Large recent insider/affiliate selling: 1,134,483 shares sold in the past three months for $203,457,192.45
• Additional proposed sale of 300,000 shares ($53.9M) on 09/03/2025 could be viewed negatively by investors absent context
• Filing lacks context about the identity/role of the seller and reasons for concentrated disposals

Insights

Financial Analyst

TL;DR: Large registered sale and heavy recent 10b5-1 activity, but no financial results disclosed in this form.

The filing documents a scheduled sale of 300,000 ARES common shares valued at $53.9 million and shows substantial prior 10b5-1 sales totaling 1,134,483 shares for $203.46 million over the past two weeks. This is a disclosure of insider selling rather than operating performance; there are no earnings, guidance, or balance-sheet details in the notice. For investment impact, market reaction will depend on context outside this form such as who the seller is and existing float dynamics, which are not provided here.

Corporate Governance Expert

TL;DR: Significant insider/affiliate liquidation activity is apparent and may raise governance questions.

The record shows founders shares originating 05/01/2014 and concentrated disposition via 10b5-1 plans and the current Form 144. Repeated sizable sales in a short window suggest a deliberate liquidity realization by related parties. While compliance steps appear followed (broker listed, Rule 10b5-1 referenced, certification of no undisclosed material information), stakeholders typically monitor the timing, beneficiaries, and any board or control changes tied to such sales; those details are not included in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	300000	53934000.00	215934693	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2014	Founders Shares	ISSUER			300000	05/01/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	09/02/2025	177929	31781250.95
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/29/2025	101032	18115633.69
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/28/2025	108374	19585685.24
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/27/2025	171686	30943534.34
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/26/2025	196197	35078081.25
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/25/2025	112522	20037388.91
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/22/2025	105394	19144535.54
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/21/2025	63378	11293281.46
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/20/2025	97971	17477801.07

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ARES disclose about the proposed sale?

The notice reports a proposed sale of 300,000 ARES common shares via Morgan Stanley on 09/03/2025 with an aggregate market value of $53,934,000.

How many ARES shares were sold by related parties in the past three months according to this filing?

The filing lists nine 10b5-1 transactions totaling 1,134,483 shares sold between 08/20/2025 and 09/02/2025.

What were the gross proceeds from the recent 10b5-1 sales reported?

The aggregated gross proceeds from those sales equal $203,457,192.45 as reported in the filing.

When and how were the 300,000 shares to be sold originally acquired?

The filing states the 300,000 shares were acquired as Founders Shares on 05/01/2014 from the issuer.

Does the Form 144 state there is undisclosed material information about ARES?

The filer certifies by signing the notice that they do not know of any material adverse information not publicly disclosed regarding the issuer.